Dietmar Zdunek

This inventor holds 20 USPTO granted patents and 35 published patent applications, plus 3 CIPO patents and 19 EPO patents. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dietmar Zdunek. Retrieved from https://idiyas.com/inventor/dietmar-zdunek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 35)

% Patents Active = 65.0

CIPO Patents = 3

EPO Patents = 19 (Patent Applications = 59)

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 29(Granted Patents)

Location History:

Tutzingen, DE (2010 - 2013)
Tutzing, DE (2011 - 2023)

Company Filing History:

20 out of 1,698

Roche Diagnostics Operations, Inc.

patents

Years Active: 2010-2023

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11719710 - GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients (2023-08-08),

2. 11047865 - Troponin and BNP based diagnosis of risk patients and cause of stroke (2021-06-29),

3. 10942175 - Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure (2021-03-09),

4. 10732188 - NT-proANP and NT-proBNP for the diagnosis of stroke (2020-08-04),

5. 9983213 - Identification of subjects being susceptible to anti-angiogenesis therapy (2018-05-29),

6. 9638700 - NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events (2017-05-02),

7. 9535073 - Prediction and recognition of acute kidney injury after surgery (2017-01-03),

8. 8771961 - Monitoring myocardial infarction and its treatment (2014-07-08),

9. 8663941 - Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction (2014-03-04),

10. 8501155 - Biochemical markers for acute pulmonary embolism (2013-08-06),

11. 8497095 - Biochemical markers for acute pulmonary embolism (2013-07-30),

12. 8486706 - L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy (2013-07-16),

13. 8440463 - Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1 (2013-05-14),

14. 8361800 - Diagnostic means and methods using troponin T and NT-proBNP (2013-01-29),

15. 8062857 - H-FABP as early predictor of myocardial infarction (2011-11-22),

Title: The Innovative Journey of Dietmar Zdunek

Introduction: Dietmar Zdunek, a pioneering inventor hailing from Tutzing, Germany, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Dietmar Zdunek holds several patents in various fields, including renewable energy technologies, advanced materials, and sustainable manufacturing processes.

Career Highlights: Throughout his illustrious career, Dietmar Zdunek has been at the forefront of technological advancements, leading research and development teams to create cutting-edge solutions that have revolutionized industries.

Collaborations: Dietmar Zdunek has collaborated with leading research institutions, universities, and multinational companies to bring his innovative ideas to life. His collaborative efforts have resulted in the successful commercialization of several patented inventions.

Conclusion: Dietmar Zdunek's passion for innovation, coupled with his relentless pursuit of excellence, has established him as a prominent figure in the world of inventions. His remarkable contributions continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.